Search results
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters via Yahoo Finance· 2 months agoPfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to...
Better Buy: Pfizer vs. Moderna
Motley Fool· 1 year agoPfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) have one big thing in common. Both companies have dominated the coronavirus vaccine market -- and aim to...
Better COVID Booster Stock: Moderna vs. Pfizer
Motley Fool· 2 years agoModerna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) have generated billions of dollars from their coronavirus vaccines. Moderna and Pfizer both have asked the...
Better Bull Market Buy: Pfizer vs. Moderna
Motley Fool via Yahoo Finance· 5 months agoCOVID-19 has been especially rough for Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) investors over the last couple of years. Shares of both drugmakers...
Moderna, Pfizer say updated COVID shots generate strong response vs newer variant
Reuters via Yahoo News· 9 months ago(Reuters) -Moderna and rival Pfizer on Wednesday said their updated COVID-19 vaccines generated...
Better Recovery Story Buy: Pfizer vs Moderna
Motley Fool via Yahoo Finance· 3 months agoA few years ago, both Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) were flying high: from an earnings and share performance perspective. They each sold...
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots?
LA Times via Yahoo News· 2 years agoVials of Pfizer's bivalent COVID-19 vaccine at a manufacturing facility in Kalamazoo, Mich. (Pfizer...
Moderna Stock Breaks Out As Cancer Vaccine Shows Promise In Keytruda Tie-Up
Investor's Business Daily· 2 years agoModerna stock broke out Tuesday after the company said adding its personalized cancer vaccine to...
Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Probably Won't Work.
Investor's Business Daily· 11 months agoThe biggest names in Covid are updating their vaccines for a fall campaign, but that might not be...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 20 hours agoDespite a bevy of promising updates for its cancer treatments, Pfizer stock remained trapped below a...